Increased serum IL-10 in lupus patients promotes apoptosis of T cell subsets via the caspase 8 pathway initiated by Fas signaling

Journal of Biomedical Research

Volumn 29, Issue 3, 2015, Pages 232-240

  Yang, Xiaofan ^a   Sun, Bin ^b   Wang, Huijuan ^a   Yin, Cheng ^a   Wang, Xiaole ^a   Ji, Xiaohui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Lupus erythematosus; Systemic; T cell

Indexed keywords

CASPASE 8; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 10;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION;

EID: 84932126367     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.29.20130037     Document Type: Article

References (21)

1. Cohen PL. Apoptotic cell death and lupus[J]. Springer Semin Immun, 2006,28(2):145-152.
2. Bouillet P, Metcalf D, Huang DC, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity[J]. Science, 1999,286(5445):1735-1738.
3. Mehrad B, Park SJ,AkangireG, et al. The lupus-susceptibility locus, Sle3, mediates enhanced resistance to bacterial infections[J]. J Immunol, 2006,176(5):3233-3239.
4. Roy V, Chang NH, Cai Y, et al. Aberrant IgM signaling promotes survival of transitional T/B cells and prevents tolerance induction in lupus-prone NewZealand black mice[J]. J Immunol, 2005,175(11):7363-7371.
5. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes form patients with systemic lupus erythematosus[J]. J Immunol, 1994,152(7):3685-3692.
6. Wang H, Xu J, Ji X, et al. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus[J]. Cell Immunol, 2005,235(2): 117-121.
7. Xue C, Lan-Lan W, Bei C, et al. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus[J]. Cell Immunol, 2006,239(2):121-128.
8. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982,25(11):1271-1277.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9):1725.
10. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients[J]. Arthritis Rheum, 1992,35(6):630-640.
11. Georgescu, L, Vakkalanka RK, Elkon KB, et al. Interleukin 10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand[J]. J Clin Invest, 1997,100(10):2622-2633.
12. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease[J]. Annu Rev Immunol, 1991,9:243-269.
13. Perniok A, Wedekind F, Herrmann M, et al. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus[J]. Lupus, 1998, 7(2):113-118.
14. Gröndal G, Traustadottir KH, Kristjansdottir H, et al. Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families[J]. Lupus, 2002,11(7):435-442.
15. Funauchi M, Sugiyama M, SukYoo B, et al. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus[J]. Lupus, 2001,10(4): 284-288.
16. Dhir V, Singh AP, Aggarwal A, et al. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study[J]. Lupus, 2009, 18(9):785-791.
17. Kalechman Y, Gafter U, Da JP, et al. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels[J]. J Immunol, 1997,159(6):2658-2667.
18. Lopez P, Gomez J, Prado C, et al. Influence of functional interleukin 10/tumor necrosis factor-a polymorphisms on interferon-a, IL-10, and regulatory T Cell population in patients with systemic lupus erythematosus receiving antimalarial treatment[J]. J Rheumatol, 2008,35(8):1559-1566.
19. Schotte H, Gaubitz M, Willeke P, et al. Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response[J]. Rheumatology, 2004,43(11):1357-1363.
20. Csiszár A, Nagy G, Gergely P, et al. Increased interferongamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)[J]. Clin Exp Immunol, 2000,122(3):464-470.
21. Viallard JF, Pellegrin JL, Ranchin V, et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)[J]. Clin Exp Immunol, 1999,115(1):189-195.